ODI PHARMA AB (6OD) — Net Asset Quality Index
ODI PHARMA AB (6OD) has a Net Asset Quality Index of 44.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €5.30 Million minus total liabilities of €2.93 Million yields net assets of €2.38 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ODI PHARMA AB balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ODI PHARMA AB Net Asset Quality Index Over Time (2022–2026)
This chart shows how ODI PHARMA AB's Net Asset Quality Index has evolved across 5 annual periods from 2022 to 2026. As of June 2026, the index stands at 44.8%, representing net assets of €2.38 Million against total assets of €5.30 Million EUR. For live market cap and overall valuation, see 6OD market cap overview.
Annual Net Asset Quality Index for ODI PHARMA AB (2022–2026)
The table below presents the year-by-year Net Asset Quality Index for ODI PHARMA AB from 2022 to 2026, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See what is ODI PHARMA AB's book value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 44.8% | €2.38 Million | €5.30 Million | €2.93 Million | ▲ +35.6 pp |
| 2025 | 9.2% | €424.64K | €4.61 Million | €4.19 Million | ▼ -7.2 pp |
| 2024 | 16.4% | €2.00 Million | €12.23 Million | €10.23 Million | ▼ -15.1 pp |
| 2023 | 31.4% | €2.57 Million | €8.19 Million | €5.61 Million | ▼ -56.8 pp |
| 2022 | 88.2% | €9.26 Million | €10.50 Million | €1.24 Million | — |